Literature DB >> 30323186

Discovery of potential causative mutations in human coding and noncoding genome with the interactive software BasePlayer.

Riku Katainen1,2, Iikki Donner3,4, Tatiana Cajuso3,4, Eevi Kaasinen3,4, Kimmo Palin3,4, Veli Mäkinen5, Lauri A Aaltonen3,4, Esa Pitkänen6,7,8.   

Abstract

Next-generation sequencing (NGS) is routinely applied in life sciences and clinical practice, but interpretation of the massive quantities of genomic data produced has become a critical challenge. The genome-wide mutation analyses enabled by NGS have had a revolutionary impact in revealing the predisposing and driving DNA alterations behind a multitude of disorders. The workflow to identify causative mutations from NGS data, for example in cancer and rare diseases, commonly involves phases such as quality filtering, case-control comparison, genome annotation, and visual validation, which require multiple processing steps and usage of various tools and scripts. To this end, we have introduced an interactive and user-friendly multi-platform-compatible software, BasePlayer, which allows scientists, regardless of bioinformatics training, to carry out variant analysis in disease genetics settings. A genome-wide scan of regulatory regions for mutation clusters can be carried out with a desktop computer in ~10 min with a dataset of 3 million somatic variants in 200 whole-genome-sequenced (WGS) cancers.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30323186     DOI: 10.1038/s41596-018-0052-3

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  12 in total

1.  Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D.

Authors:  Taina T Nieminen; Christopher J Walker; Alisa Olkinuora; Luke K Genutis; Margaret O'Malley; Paul E Wakely; Lisa LaGuardia; Laura Koskenvuo; Johanna Arola; Anna H Lepistö; Pamela Brock; Ayse Selen Yilmaz; Ann-Kathrin Eisfeld; James M Church; Päivi Peltomäki; Albert de la Chapelle
Journal:  Thyroid       Date:  2020-03       Impact factor: 6.568

2.  Identification of Rare Variants Predisposing to Thyroid Cancer.

Authors:  Yanqiang Wang; Sandya Liyanarachchi; Katherine E Miller; Taina T Nieminen; Daniel F Comiskey; Wei Li; Pamela Brock; David E Symer; Keiko Akagi; Katherine E DeLap; Huiling He; Daniel C Koboldt; Albert de la Chapelle
Journal:  Thyroid       Date:  2019-05-13       Impact factor: 6.568

3.  A novel essential splice site variant in SPTB in a large hereditary spherocytosis family.

Authors:  Taina T Nieminen; Sandya Liyanarachchi; Daniel F Comiskey; Yanqiang Wang; Wei Li; Isabella V Hendrickson; Pamela Brock; Albert de la Chapelle; Huiling He
Journal:  Mol Genet Genomic Med       Date:  2021-05-04       Impact factor: 2.183

4.  Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans.

Authors:  Eevi Kaasinen; Outi Kuismin; Kristiina Rajamäki; Heikki Ristolainen; Mervi Aavikko; Johanna Kondelin; Silva Saarinen; Davide G Berta; Riku Katainen; Elina A M Hirvonen; Auli Karhu; Aurora Taira; Tomas Tanskanen; Amjad Alkodsi; Minna Taipale; Ekaterina Morgunova; Kaarle Franssila; Rainer Lehtonen; Markus Mäkinen; Kristiina Aittomäki; Aarno Palotie; Mitja I Kurki; Olli Pietiläinen; Morgane Hilpert; Elmo Saarentaus; Jaakko Niinimäki; Juhani Junttila; Kari Kaikkonen; Pia Vahteristo; Radek C Skoda; Mikko R J Seppänen; Kari K Eklund; Jussi Taipale; Outi Kilpivaara; Lauri A Aaltonen
Journal:  Nat Commun       Date:  2019-03-19       Impact factor: 14.919

5.  Exome and immune cell score analyses reveal great variation within synchronous primary colorectal cancers.

Authors:  Ulrika A Hänninen; Erkki-Ville Wirta; Riku Katainen; Tomas Tanskanen; Jiri Hamberg; Minna Taipale; Jan Böhm; Laura Renkonen-Sinisalo; Anna Lepistö; Linda M Forsström; Esa Pitkänen; Kimmo Palin; Toni T Seppälä; Netta Mäkinen; Jukka-Pekka Mecklin; Lauri A Aaltonen
Journal:  Br J Cancer       Date:  2019-03-21       Impact factor: 7.640

6.  Colibactin DNA-damage signature indicates mutational impact in colorectal cancer.

Authors:  Paulina J Dziubańska-Kusibab; Hilmar Berger; Federica Battistini; Britta A M Bouwman; Amina Iftekhar; Riku Katainen; Tatiana Cajuso; Nicola Crosetto; Modesto Orozco; Lauri A Aaltonen; Thomas F Meyer
Journal:  Nat Med       Date:  2020-06-01       Impact factor: 53.440

7.  Candidate Predisposition Variants in Kaposi Sarcoma as Detected by Whole-Genome Sequencing.

Authors:  Sanni J Rinne; Lauri J Sipilä; Päivi Sulo; Emmanuelle Jouanguy; Vivien Béziat; Laurent Abel; Jean-Laurent Casanova; Nima Parvaneh; Kamran Balighi; Emma Guttman-Yassky; Ronit Sarid; Lauri A Aaltonen; Mervi Aavikko
Journal:  Open Forum Infect Dis       Date:  2019-07-17       Impact factor: 3.835

Review 8.  Visualization tools for human structural variations identified by whole-genome sequencing.

Authors:  Toshiyuki T Yokoyama; Masahiro Kasahara
Journal:  J Hum Genet       Date:  2019-10-30       Impact factor: 3.172

9.  Novel germline variant in the histone demethylase and transcription regulator KDM4C induces a multi-cancer phenotype.

Authors:  Riku Katainen; Iikki Donner; Maritta Räisänen; Davide Berta; Anna Kuosmanen; Eevi Kaasinen; Marja Hietala; Lauri A Aaltonen
Journal:  J Med Genet       Date:  2021-07-19       Impact factor: 5.941

10.  WNT2 activation through proximal germline deletion predisposes to small intestinal neuroendocrine tumors and intestinal adenocarcinomas.

Authors:  Mervi Aavikko; Eevi Kaasinen; Noora Andersson; Nalle Pentinmikko; Päivi Sulo; Iikki Donner; Päivi Pihlajamaa; Anna Kuosmanen; Simona Bramante; Riku Katainen; Lauri J Sipilä; Samantha Martin; Johanna Arola; Olli Carpén; Ilkka Heiskanen; Jukka-Pekka Mecklin; Jussi Taipale; Ari Ristimäki; Kaisa Lehti; Erika Gucciardo; Pekka Katajisto; Camilla Schalin-Jäntti; Pia Vahteristo; Lauri A Aaltonen
Journal:  Hum Mol Genet       Date:  2021-11-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.